miR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma

E-ISSN： 1791-2431|32|6|2365-2372

ISSN： 1021-335X

Source： Oncology Reports, Vol.32, Iss.6, 2014-01, pp. : 2365-2372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-106b~25 cluster regulates multidrug resistance in an ABC transporter-independent manner via downregulation of EP300

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 1170-1178

Spandidos Publications

Access to resources Recommend Favorite

Chemotherapy for Malignant Pleural Mesothelioma

By Garland Linda

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Malignant pleural mesothelioma

By Stahel Rolf A Felley-Bosco Emanuela Opitz Isabelle Weder Walter

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

miR222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1537-1546

Spandidos Publications

Access to resources Recommend Favorite

Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines

By Kitazono-Saitoh Miyako Takiguchi Yuichi Kitazono Satoru Ashinuma Hironori Kitamura Atsushi Tada Yuji Kurosu Katsushi Sakaida Emiko Sekine Ikuo Tanabe Nobuhiro Tagawa Masatoshi Tatsumi Koichiro

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 33-40

Spandidos Publications

Access to resources Recommend Favorite